Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezosentan in pulmonary arterial hypertension
NCT01077297Phase 2Terminated
- Sponsor
- Idorsia
- Start
- Aug 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tezosentan in pulmonary arterial hypertension (PAH), sponsored by Idorsia. Started Aug 2010; status: terminated.
02
Drugs
tezosentan
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01077297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077297.